Nucleic Acids Research preferences has been limited to camparison of binding isotherms obtained by spectrophotometric analyses of drug binding to hanopolymer and copolymer nucleic acids.(3) One direct method reported for determining the binding sites of small molecules with binding site sizes in the range of three to four base pairs on heterogeneous DNA is MPE*Fe(II) footprinting. (7) (8) (9) Methidiumpropyl-EDTA (MPE) , which contains the DNA intercalator, methidium, covalently bound by a short hydrocarbon tether to the metal chelator, EDTA, efficiently produces single strand breaks in double helical DNA in the presence of Fe(II) and 02. (Figure 1 ) (10) Importantly, MPE*Fe(II) is a relatively non-sequence specific DNA cleaving agent with lower sequence specificity than DNase I.(7-9) Using MPE*Fe(II) footprinting, the binding sites of actinomycin, netropsin, distamycin, chrcmomycin, mithramycin, and olivomycin over a range of binding densities on some DNA restriction fragments have been determined. (7) (8) (9) The DNA cleavage inhibition patterns (footprints) on opposite strands are asymmetric, shifted at least one base pair to the 3' side of the presumed drug binding site. (8, 9) Recently, DNase I has been shown capable of generating DNA cleavage inhibition patterns with actinomycin and distamycin at very low binding densities.(ll) The question arises whether MPE-Fe(II) and DNase I footprinting report the same information. It is not obvious whether the synthetic MPE-Fe(II) and the enzyme DNase I are equally sensitive to the same phenomiena. They are comnon because they are both DNA cleaving reagents. Hawever, they differ in size, mechanism of cleavage, and level of sequence neutrality. We report here a oomparison between MPE-Fe(II) and DNase I footprinting patterns generated on DNA fragments protected by actinomycin D, chromomycin A3 and distamycin A. Figure 5 . For actinomycin Di, MPE-Fe(II) partial cleavage reveals six footprints 2-5 base pairs in size. DNase I partial cleavage exhibits three footprints, two [5] [6] MWv.
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